Class II non-muscle myosins are implicated in diverse biological processes such as cytokinesis, cellularization, cell shape changes and gastrulation. Two distinct non-muscle myosin heavy chain genes have been reported in all vertebrates: non-muscle myosin heavy chain-A (NMHC-A) and -B (NMHC-B). We report here the isolation of the Xenopus homolog of NMHC-A and present a comparative analysis of the developmental and spatial expression patterns of NMHC-A and the previously isolated NMHC-B to address the role of NMHCs in Xenopus development. A 7.5 kb NMHC-A mRNA is present, maternally in unfertilized eggs and throughout embryogenesis, as well as in all adult tissues examined. An additional 8.3 kb zygotic transcript for NMHC-A is also detected, but only during embryonic stages. Whole mount in situ hybridization with tailbud stage embryos shows that NMHC-A mRNA is predominantly expressed in the epidermis, whereas NMHC-B mRNA is expressed in the somites, brain, eyes and branchial arches. Interestingly, the expression of NMHC-B in developing somites is gradually restricted to the center of each somite as differentiation proceeds. DAPI nuclear staining demonstrated that NMHC-B mRNA is colocalized with the nuclei or perinuclear area. In animal cap experiments, treatment with activin A or ectopic expression of Xbra and an activated form of Xlim1 markedly up-regulates NMHC-B as well as muscle actin mRNAs and slightly down-regulates NMHC-A mRNA, consistent with NMHC-B expression in the somitic muscle and NMHC-A expression in the epidermis.
Results
The cDNA encoding the entire open reading frame (ORF) of Xenopus NMHC-A was obtained by joining together two overlapping cDNA clones, xen12 and xen10. The combined sequence contains 88 bp in the 5′UTR followed by an ORF of 5892 bp and the entire 3′UTR consisting of 981 bp followed by a short poly(A) tail. (GenBank AF055895).
NMHC-A mRNA, approximately 7.5 kb, is initially detected by RNA blotting as a single maternal transcript in the early stages of embryogenesis and then as a zygotic transcript at later stages (Fig. 1a) . At embryonic stage 15, an additional zygotic transcript of about 8.3 kb is detected, peaking between stages 25 and 30. Around stage 40, its expression declines and it is only faintly detectable at stage 47. The 7.5 kb transcript is detected in all adult tissues and cell lines (XTC and A6) examined, particularly lung, spleen, kidney and pancreas (Fig. 1b) . The larger 8.3 kb transcript is not detectable in any of the adult tissues or cell lines examined.
We performed whole mount in situ hybridization to determine the spatial distribution of mRNA for NMHC-A as well as for the previously isolated NMHC-B (Bhatia-Dey et al., 1993) at different embryonic stages. The maternal transcripts of NMHC-A do not appear to be localized at the blastula and gastrula stages (data not shown). Fig. 2a NMHC-A antisense probe showing uniform staining throughout the embryo. A strong signal for NMHC-A mRNA is detected in the epidermis surrounding the embryo, whereas the signal in the somites (s) and the notochord (n) is barely detectable (Fig. 2c) .
In contrast to NMHC-A, the expression of NMHC-B is specifically detected in the developing somites and the central nervous system. NMHC-B transcripts begin to concentrate in a rostro-caudal direction in the developing somites around mid-neurulation (data not shown).
In a stage 23 embryo (Fig. 2d) , a signal is detected in differentiated somites as narrow stripes. A tailbud embryo (Fig. 2e) illustrates the fully formed expression pattern. The staining in the somites continues to concentrate as thin dark stripes, whereas the undifferentiated, presomitic mesoderm located at the caudal end has a relatively weak and diffuse signal as seen at the earlier stages. The staining is also detected in the head region, pronephros, otic vesicle and branchial arches (Fig. 2e,f) . To further analyze the localized expression of NMHC-B mRNA in somites, the stained embryos were sectioned and stained with DAPI to visualize nuclei. Fig. 2g (left panel) illustrates the thin stripes of NMHC-B mRNA in the differentiated somites. DAPI staining (middle panel) illustrates that the signal for NMHC-B mRNA is primarily confined to the nuclear or perinuclear regions as shown in the dual exposure (right panel). Thus, the expression pattern of NMHC-B in the somites clearly differs from that reported by Radice (1995) for skeletal muscle MHCs, although the biological significance of the intracellular localization of NMHC-B mRNA is not known.
To examine the correlation between tissue differentiation and NMHC-A and NMHC-B expression, we performed experiments using animal caps. Isolated animal caps from blastula stage embryos differentiate into atypical epidermis when cultured alone, whereas they differentiate into mesodermal derivatives with either treatment by activin A or with microinjection of Xbra and Xlim1/3m mRNAs (Taira et al., 1994) . Untreated animal caps that differentiate into atypical epidermis, express two transcripts of NMHC-A, but only small amounts of NMHC-B mRNAs, and no skeletal muscle actin mRNA (Fig. 3, lane 1) . Treatment with activin (lane 5) shows a slight decrease in NMHC-A expression, but a marked increase in both NMHC-B and skeletal muscle actin expression (compare lanes 1 and 5). Furthermore, injection of Xbra or Xlim1/3m mRNA, which converts ectoderm into ventral-type mesoderm (Cunliffe and Smith, 1992) or neural tissue (Taira et al., 1994) , respectively, initiates down-regulation of NMHC-A mRNA expression (lanes 2 and 4). This reduction is not significantly changed by coinjection of Xbra and Xlim1/3m (lane 3), suggesting that down-regulation of NMHC-A mRNA is due to decreased development of atypical epidermis. In contrast, up-regulation of NMHC-B and skeletal muscle actin mRNA is initiated by injection of Xbra mRNA (lane 2), which levels are further increased by coexpression with Xlim1/ 3m (lane 3). These results are consistent with NMHC-A expression being predominant in the epidermis and NMHC-B expression being primarily in the somites.
Experimental procedures
A lZAP (Stratagene, La Jolla, CA) XTC cell cDNA library was screened with polyclonal antibodies raised against human platelet myosin ( Kawamoto and Adelstein, 1987) . Total RNA was isolated from embryos and adult tissues using RNA stat-60 (Teltest, Friendswood, TX) followed by LiCl precipitation unless otherwise indicated. Blot hybridization and mRNA injection experiments were described previously (Taira et al., 1994) . Whole mount in situ hybridization with albino embryos was performed following the method described by Harland (1991) . Digoxigenin-labeled probes of NMHC-A (nt 5575-6936) and NMHC-B (clone x181, Bhatia-Dey et al., 1993) cDNA included part of the rod region and the entire 3′ untranslated region. Stained embryos were dehydrated, immersed in xylene, and embedded in Paraplast (Oxford Labware). Fifteen or twenty mm sections were collected on silanated slides. The slides were stained in 80 ng/ml of DAPI in 2 × SSC. 3 . RNA blot analysis of animal caps. Total RNAs were isolated from animal caps which were injected as indicated (lanes 1-4) or treated with 50 pM activin (lane 5). Lane 6, whole embryos (stage 22). The injected RNAs are denoted above the lanes as +(l ng/embryo) − or next to each synthetic mRNA labeled on the left. Total RNA was isolated as described previously (Taira et al., 1994) and loaded on a gel at 5 mg per lane. The ethidium bromide stained 18S ribosomal RNA is shown as a loading control.
